Prestige Consumer Healthcare (PBH) Net Cash Flow Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Net Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -1,020.00% |
| 10 | Prestige Consumer Healthcare | 2.41 Bn | 2.35 Bn | 157.37 Mn | -4,142.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,142.91% |
| Sep 30, 2025 | -223.04% |
| Jun 30, 2025 | 416.81% |
| Mar 31, 2025 | 383.42% |
| Dec 31, 2024 | -33.90% |
| Sep 30, 2024 | 177.28% |
| Jun 30, 2024 | -241.63% |
| Mar 31, 2024 | 40.64% |
| Dec 31, 2023 | -95.05% |
| Sep 30, 2023 | -17.08% |
| Jun 30, 2023 | -138.36% |
| Mar 31, 2023 | -587.34% |
| Dec 31, 2022 | 299.90% |
| Sep 30, 2022 | 106.01% |
| Jun 30, 2022 | -92.54% |
| Mar 31, 2022 | 119.37% |
| Dec 31, 2021 | -162.60% |
| Sep 30, 2021 | -272.12% |
| Jun 30, 2021 | 439.60% |
| Mar 31, 2021 | -143.14% |